{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:45:32Z","timestamp":1794530732954,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is still a dearth of knowledge on the burden of HEV infection in the global population of pregnant women. Therefore, we conducted a systematic review and meta-analysis to estimate the global burden of HEV infection in pregnancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched PubMed, Embase, Web of Knowledge, and Global Index Medicus to identify articles published until January 26, 2020. We considered cross-sectional, case-control, and cohort studies reporting the immunoglobulins M HEV seroprevalence in asymptomatic and symptomatic (jaundice or elevated transaminases) pregnant women or investigating the association between HEV infection and maternofoetal outcomes. We used a random-effects model to pool studies. This review was registered with PROSPERO, CRD42018093820.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>For HEV prevalence estimates, we included 52 studies (11,663 pregnant women). The seroprevalence was 3.5% (95% confidence interval: 1.4\u20136.4) in asymptomatic women (most of whom from high endemic areas). The prevalence in symptomatic women was 49.6% (42.6\u201356.7) with data only from HEV high endemic countries. In the multivariable meta-regression model, the prevalence was higher in symptomatic women compared to asymptomatic (adjusted prevalence odds ratio [aPOR]: 1.76; 95%CI: 1.61\u20131.91) and decreased with increasing year of publication (by 10-year) (aPOR: 0.90; 95%CI: 0.84\u20130.96). The proportion of HEV vertical transmission was 36.9% (13.3\u201364.2). Risk of bias was low, moderate and high respectively in 12 (23%), 37 (70%), and 4 studies (7%) addressing HEV prevalence estimation. HEV infection was associated with maternal deaths (pooled OR 7.17; 3.32\u201315.47), low birth weight (OR: 3.23; 1.71\u20136.10), small for gestational age (OR: 3.63; 1.25\u201310.49), preterm &lt;\u200932\u2009weeks (OR: 4.18; 1.23\u201314.20), and preterm &lt;\u200937\u2009weeks (OR: 3.45; 2.32\u20135.13), stillbirth (OR: 2.61; 1.64\u20134.14), intrauterine deaths (OR: 3.07; 2.13\u20134.43), and not with miscarriage (OR: 1.74; 0.77\u20133.90). All studies which assessed the association between HEV infection and maternofoetal outcomes had a moderate risk of bias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings from this study are suggestive of a high burden of HEV infection in pregnancy in high endemic countries, its association with poor maternofoetal outcomes, and a high rate of vertical transmission. This study supports the need for specific strategies to prevent exposure of pregnant women to HEV infection, especially in high endemic areas.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-020-03116-2","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T12:02:53Z","timestamp":1595937773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-6279","authenticated-orcid":false,"given":"Jean Joel","family":"Bigna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdou Fatawou","family":"Modiyinji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobert Richie","family":"Nansseu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"Amougou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moise","family":"Nola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Kenmoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis","family":"Temfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Njouom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"3116_CR1","unstructured":"World Health Organization. Global Health sector strategy on viral hepatitis 2016-2021: Towards ending viral hepatitis. WHO: 2016. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf;jsessionid=8BBB114FF64FC1E901805FA54462BE1?sequence=1."},{"key":"3116_CR2","unstructured":"WHO: Global Hepatitis Report: Prevent, test and treat. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455-eng.pdf?sequence=1. Accessed on Jul 6, 2018."},{"key":"3116_CR3","unstructured":"WHO: Hepatitis E: Key facts. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e. Accessed on June 9, 2018."},{"key":"3116_CR4","doi-asserted-by":"crossref","unstructured":"Dalton HR, Izopet J. Transmission and epidemiology of hepatitis E virus genotype 3 and 4 infections. Cold Spring Harbor Perspect Med. 2018;18(11):a032144. https:\/\/pubmed.ncbi.nlm.nih.gov\/29530946\/.","DOI":"10.1101\/cshperspect.a032144"},{"issue":"3","key":"3116_CR5","first-page":"176","volume":"24","author":"J Izopet","year":"2017","unstructured":"Izopet J, Lhomme S, Chapuy-Regaud S, Mansuy JM, Kamar N, Abravanel F. HEV and transfusion-recipient risk. VHE Risque receveur. 2017;24(3):176\u201381.","journal-title":"VHE Risque receveur"},{"issue":"4","key":"3116_CR6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/liv.12629","volume":"35","author":"DB Smith","year":"2015","unstructured":"Smith DB, Simmonds P. Hepatitis E virus and fulminant hepatitis--a virus or host-specific pathology? Liver Int. 2015;35(4):1334\u201340.","journal-title":"Liver Int"},{"issue":"5","key":"3116_CR7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1440-1746.2007.04913.x","volume":"22","author":"N Jilani","year":"2007","unstructured":"Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22(5):676\u201382.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"3116_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/jmv.23508","volume":"85","author":"J Borkakoti","year":"2013","unstructured":"Borkakoti J, Hazam RK, Mohammad A, Kumar A, Kar P. Does high viral load of hepatitis E virus influence the severity and prognosis of acute liver failure during pregnancy? J Med Virol. 2013;85(4):620\u20136.","journal-title":"J Med Virol"},{"issue":"9","key":"3116_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/j.1478-3231.2008.01840.x","volume":"28","author":"U Navaneethan","year":"2008","unstructured":"Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008;28(9):1190\u20139.","journal-title":"Liver Int"},{"issue":"7","key":"3116_CR10","first-page":"607","volume":"61","author":"SA Chaudhry","year":"2015","unstructured":"Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Phys Med Fam Can. 2015;61(7):607\u20138.","journal-title":"Can Fam Phys Med Fam Can"},{"key":"3116_CR11","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clin Res ed). 2009;339:b2700.","journal-title":"BMJ (Clin Res ed)"},{"key":"3116_CR12","unstructured":"WHO: Waterborne outbreaks of Hepatitis E: Recognition, Investigation, and Control. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/129448\/9789241507608_eng.pdf?sequence=1. Accessed on Jul 01, 2018."},{"issue":"9","key":"3116_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"3116_CR14","first-page":"i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res). 2016;355:i4919.","journal-title":"BMJ (Clin Res)"},{"issue":"5","key":"3116_CR15","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360\u20133.","journal-title":"Fam Med"},{"issue":"11","key":"3116_CR16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138.","journal-title":"J Epidemiol Community Health"},{"issue":"7109","key":"3116_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res). 1997;315(7109):629\u201334.","journal-title":"BMJ (Clin Res)"},{"issue":"Pt A","key":"3116_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139\u201345.","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"3116_CR19","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"1","key":"3116_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101\u201329.","journal-title":"Biometrics"},{"issue":"7","key":"3116_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/jog.12986","volume":"42","author":"G Bhatnagar","year":"2016","unstructured":"Bhatnagar G, Sharma S, Kumar A, Prasad S, Agarwal S, Kar P. Reduced glutathione in hepatitis E infection and pregnancy outcome. J Obstet Gynaecol Res. 2016;42(7):789\u201395.","journal-title":"J Obstet Gynaecol Res"},{"issue":"8","key":"3116_CR22","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jmv.23925","volume":"86","author":"SG Devi","year":"2014","unstructured":"Devi SG, Kumar A, Kar P, Husain SA, Sharma S. Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol. 2014;86(8):1366\u201376.","journal-title":"J Med Virol"},{"issue":"8","key":"3116_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.26719\/2017.23.8.559","volume":"23","author":"NA Javed","year":"2017","unstructured":"Javed NA, Ullah SH, Hussain N, Sheikh MA, Khan A, Ghafoor F, Firdous R, Uddin W, Saqib AN, Muhyudin G. Hepatitis e virus seroprevalence in pregnant women in Pakistan: maternal and fetal outcomes. East Mediterr Health J. 2017;23(8):559\u201363.","journal-title":"East Mediterr Health J"},{"issue":"1","key":"3116_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cyto.2013.09.022","volume":"65","author":"A Kumar","year":"2014","unstructured":"Kumar A, Devi SG, Kar P, Agarwal S, Husain SA, Gupta RK, Sharma S. Association of cytokines in hepatitis E with pregnancy outcome. Cytokine. 2014;65(1):95\u2013104.","journal-title":"Cytokine"},{"issue":"1","key":"3116_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-147-1-200707030-00005","volume":"147","author":"S Patra","year":"2007","unstructured":"Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28\u201333.","journal-title":"Ann Intern Med"},{"key":"3116_CR26","doi-asserted-by":"crossref","unstructured":"Abebe M, Ali I, Ayele S, Overbo J, Aseffa A, Mihret A. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia. PLoS One. 2017;12(6).","DOI":"10.1371\/journal.pone.0180078"},{"key":"3116_CR27","doi-asserted-by":"crossref","unstructured":"Adjei AA, Tettey Y, Aviyase JT, Adu-Gyamfi C, Obed S, Mingle JA, Ayeh-Kumi PF, Adiku TK. Hepatitis e virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J. 2009;6.","DOI":"10.1186\/1743-422X-6-108"},{"issue":"10","key":"3116_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/jmv.21284","volume":"80","author":"RE Ahmed","year":"2008","unstructured":"Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol. 2008;80(10):1747\u20138.","journal-title":"J Med Virol"},{"issue":"3","key":"3116_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13224-014-0666-5","volume":"66","author":"A Singla","year":"2016","unstructured":"Singla A, Mehta S, Rajaram S, Shree S. Materno-fetal outcomes with viral hepatitis in pregnancy. J Obstet Gynecol India. 2016;66(3):166\u20139.","journal-title":"J Obstet Gynecol India"},{"issue":"1","key":"3116_CR30","first-page":"6","volume":"26","author":"VS Banait","year":"2007","unstructured":"Banait VS, Sandur V, Parikh F, Murugesh M, Ranka P, Ramesh VS, Sasidharan M, Sattar A, Kamat S, Dalal A, et al. Outcome of acute liver failuredue to acute hepatitis E in pregnant women. Indian J Gastroenterol. 2007;26(1):6\u201310.","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"3116_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0255-0857(21)03069-3","volume":"21","author":"M Beniwal","year":"2003","unstructured":"Beniwal M, Kumar A, Kar P, Jilani N, Sharma JB. Prevalence and severity of acute viral hepatitis and fulminant hepatitis during pregnancy: a prospective study from North India. Indian J Med Microbiol. 2003;21(3):184\u20135.","journal-title":"Indian J Med Microbiol"},{"issue":"5","key":"3116_CR32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.22493","volume":"48","author":"V Bhatia","year":"2008","unstructured":"Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: Is the prognosis really worse? Hepatology (Baltimore, Md). 2008;48(5):1577\u201385.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"161","key":"3116_CR33","first-page":"182","volume":"45","author":"BK Bista","year":"2006","unstructured":"Bista BK, Rana A. Acute hepatitis E in pregnancy--study of 16 cases. JNMA. 2006;45(161):182\u20135.","journal-title":"JNMA"},{"issue":"9","key":"3116_CR34","first-page":"1168","volume":"63","author":"ZP Brohi","year":"2013","unstructured":"Brohi ZP, Sadaf A, Perveen U. Etiology, clinical features and outcome of fulminant hepatic failure in pregnancy. J Pak Med Assoc. 2013;63(9):1168\u201371.","journal-title":"J Pak Med Assoc"},{"key":"3116_CR35","unstructured":"Cordova CMMd, Blatt SL, Botelho TKR, Dalmarco EM: Sorologia Para o v\u00edrus da Hepatite E em gestantes: clinicamente importante ou desnecess\u00e1rio? Rev Bras Anal Clin 2007, 39(4):269\u2013273."},{"issue":"1","key":"3116_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1341-8076.2004.00155.x","volume":"30","author":"AS Cevrioglu","year":"2004","unstructured":"Cevrioglu AS, Altindis M, Tanir HM, Aksoy F. Investigation of the incidence of hepatitis E virus among pregnant women in Turkey. J Obstet Gynaecol Res. 2004;30(1):48\u201352.","journal-title":"J Obstet Gynaecol Res"},{"key":"3116_CR37","doi-asserted-by":"crossref","unstructured":"Changede P, Chavan N, Raj N, Gupta P. An observational study to evaluate the maternal and Foetal outcomes in pregnancies complicated with jaundice. J Obstet Gynecol India. 2018:1\u20136.","DOI":"10.1007\/s13224-018-1105-9"},{"issue":"3","key":"3116_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jmv.24058","volume":"87","author":"W Cong","year":"2015","unstructured":"Cong W, Sui JC, Zhang XY, Qian AD, Chen J, Zhu XQ. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China. J Med Virol. 2015;87(3):446\u201350.","journal-title":"J Med Virol"},{"issue":"1","key":"3116_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/tmi.12632","volume":"21","author":"M De Paschale","year":"2016","unstructured":"De Paschale M, Ceriani C, Roman\u00f2 L, Cerulli T, Cagnin D, Cavallari S, Ndayake J, Zaongo D, Diombo K, Priuli G, et al. Epidemiology of hepatitis E virus infection during pregnancy in Benin. Trop Med Int Health. 2016;21(1):108\u201313.","journal-title":"Trop Med Int Health"},{"key":"3116_CR40","doi-asserted-by":"crossref","unstructured":"Elduma AH, Osman WM. Dengue and hepatitis E virus infection in pregnant women in eastern Sudan, a challenge for diagnosis in an endemic area. Pan African Med J. 2014;19.","DOI":"10.11604\/pamj.2014.19.391.5439"},{"key":"3116_CR41","doi-asserted-by":"crossref","unstructured":"Farshadpour F, Taherkhani R, Ravanbod MR, Eghbali SS, Taherkhani S, Mahdavi E. Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS One. 2018;13(1).","DOI":"10.1371\/journal.pone.0191090"},{"issue":"1","key":"3116_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0168-8278(96)80323-0","volume":"25","author":"SS Hamid","year":"1996","unstructured":"Hamid SS, Jafri SMW, Khan H, Shah H, Abbas Z, Fields H. Fulminant hepatic failure in pregnant women: acute fatty liver or acute vital hepatitis? J Hepatol. 1996;25(1):20\u20137.","journal-title":"J Hepatol"},{"issue":"5","key":"3116_CR43","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.patbio.2009.06.004","volume":"59","author":"N Hannachi","year":"2011","unstructured":"Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, Ghannem H, Khairi H, Boukadida J. Seroprevalence and risk factors of hepatitis E among pregnant women in Central Tunisia. Pathol Biol. 2011;59(5):e115\u20138.","journal-title":"Pathol Biol"},{"issue":"6","key":"3116_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bjid.2013.02.006","volume":"17","author":"F Huang","year":"2013","unstructured":"Huang F, Ma T, Li L, Zeng W, Jing S. Low seroprevalence of hepatitis E virus infection in pregnant women in Yunnan, China. Braz J Infect Dis. 2013;17(6):716\u20137.","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"3116_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.bjid.2015.08.009","volume":"19","author":"F Huang","year":"2015","unstructured":"Huang F, Wang J, Yang C, Long F, Li Y, Li L, Jing S, Wang H. Chinese pregnant women in their third trimester are more susceptible to HEV infection. Braz J Infect Dis. 2015;19(6):672\u20134.","journal-title":"Braz J Infect Dis"},{"issue":"2","key":"3116_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0020-7292(00)00264-2","volume":"72","author":"SPB Jaiswal","year":"2001","unstructured":"Jaiswal SPB, Jain AK, Naik G, Soni N, Chitnis DS. Viral hepatitis during pregnancy. Int J Gynecol Obstet. 2001;72(2):103\u20138.","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"3116_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1440-1746.2007.04913.x","volume":"22","author":"N Jilani","year":"2007","unstructured":"Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol (Australia). 2007;22(5):676\u201382.","journal-title":"J Gastroenterol Hepatol (Australia)"},{"key":"3116_CR48","first-page":"15","volume":"5","author":"SA Junaid","year":"2014","unstructured":"Junaid SA, Agina SE, Abubakar KA. Epidemiology and associated risk factors of hepatitis E virus infection in plateau state, Nigeria. Virology. 2014;5:15\u201326.","journal-title":"Virology"},{"issue":"10","key":"3116_CR49","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/j.1572-0241.2008.02032.x","volume":"103","author":"P Kar","year":"2008","unstructured":"Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, Das BC. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103(10):2495\u2013501.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3116_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2893.2003.00398.x","volume":"10","author":"MS Khuroo","year":"2003","unstructured":"Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat. 2003;10(1):61\u20139.","journal-title":"J Viral Hepat"},{"issue":"3","key":"3116_CR51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1365-2893.2003.00415.x","volume":"10","author":"MS Khuroo","year":"2003","unstructured":"Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat. 2003;10(3):224\u201331.","journal-title":"J Viral Hepat"},{"issue":"5","key":"3116_CR52","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00404-017-4501-y","volume":"296","author":"A Kumar","year":"2017","unstructured":"Kumar A, Sharma S, Kar P, Agarwal S, Ramji S, Husain SA, Prasad S, Sharma S. Impact of maternal nutrition in hepatitis E infection in pregnancy. Arch Gynecol Obstet. 2017;296(5):885\u201395.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"3116_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.diagmicrobio.2011.06.019","volume":"71","author":"S Kumar","year":"2011","unstructured":"Kumar S, Pujhari SK, Chawla YK, Chakraborti A, Ratho RK. Molecular detection and sequence analysis of hepatitis E virus in patients with viral hepatitis from North India. Diagn Microbiol Infect Dis. 2011;71(2):110\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3116_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0301-2115(01)00448-1","volume":"100","author":"RM Kumar","year":"2001","unstructured":"Kumar RM, Uduman S, Rana S, Kochiyil JK, Usmani A, Thomas L. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol. 2001;100(1):9\u201315.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"3116_CR55","first-page":"106","volume":"14","author":"N Kumar","year":"2017","unstructured":"Kumar N, Das V, Agarwal A, Pandey A, Agrawal S. Fetomaternal outcomes in pregnant women with hepatitis e infection; still an important fetomaternal killer with an unresolved mystery of increased virulence in pregnancy. Turk Jinekoloji Obstet Dernegi Dergisi. 2017;14(2):106\u201313.","journal-title":"Turk Jinekoloji Obstet Dernegi Dergisi"},{"issue":"6","key":"3116_CR56","first-page":"596","volume":"6","author":"S Kumar","year":"2007","unstructured":"Kumar S, Ratho RK, Chawla YK, Chakraborti A. The incidence of sporadic viral hepatitis in North India: a preliminary study. Hepatobil Pancreatic Dis Int. 2007;6(6):596\u20139.","journal-title":"Hepatobil Pancreatic Dis Int"},{"issue":"3","key":"3116_CR57","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ijgo.2003.11.018","volume":"85","author":"A Kumar","year":"2004","unstructured":"Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynecol Obstet. 2004;85(3):240\u20134.","journal-title":"Int J Gynecol Obstet"},{"issue":"10","key":"3116_CR58","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/jmv.21840","volume":"82","author":"MLM Lindemann","year":"2010","unstructured":"Lindemann MLM, Gabilondo G, Romero B, De La Maza OMS, P\u00e9rez-Gracia MT. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. J Med Virol. 2010;82(10):1666\u20138.","journal-title":"J Med Virol"},{"issue":"2","key":"3116_CR59","first-page":"161","volume":"7","author":"MA Mahtab","year":"2008","unstructured":"Mahtab MA, Rahman S, Khan M, Mamum AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobil Pancreatic Dis Int. 2008;7(2):161\u20134.","journal-title":"Hepatobil Pancreatic Dis Int"},{"key":"3116_CR60","doi-asserted-by":"crossref","unstructured":"Neffatti H, Lebraud P, Hottelet C, Gharbi J, Challouf T, Roque-Afonso AM. Southern Tunisia: A still high endemicity area for hepatitis A. PLoS One. 2017;12(4).","DOI":"10.1371\/journal.pone.0175887"},{"key":"3116_CR61","doi-asserted-by":"crossref","unstructured":"Obiri-Yeboah D, Awuku YA, Adu J, Pappoe F, Obboh E, Nsiah P, Amoako-Sakyi D, Simpore J. Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. PLoS One. 2018;13(1).","DOI":"10.1371\/journal.pone.0191685"},{"issue":"3","key":"3116_CR62","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/jmv.1890420305","volume":"42","author":"FH Pujol","year":"1994","unstructured":"Pujol FH, Favorov MO, Marcano T, Este JA, Magris M, Liprandi F, Khudyakov YE, Khudyakova NS, Fields HA. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol. 1994;42(3):234\u20136.","journal-title":"J Med Virol"},{"issue":"2","key":"3116_CR63","first-page":"59","volume":"26","author":"U Rathi","year":"2007","unstructured":"Rathi U, Bapat M, Rathi P, Abraham P. Effect of liver disease on maternal and fetal outcome a prospective study. Indian J Gastroenterol. 2007;26(2):59\u201363.","journal-title":"Indian J Gastroenterol"},{"key":"3116_CR64","doi-asserted-by":"crossref","unstructured":"Renou C, Gobert V, Locher C, Moumen A, Timbely O, Savary J, Roque-Afonso AM. Prospective study of Hepatitis e Virus infection among pregnant women in France. Virol J. 2014;11(1).","DOI":"10.1186\/1743-422X-11-68"},{"issue":"1","key":"3116_CR65","first-page":"28","volume":"63","author":"S Sahai","year":"2015","unstructured":"Sahai S, Mishra V, Ganga D, Jatav OP. Viral hepatitis in pregnancy--a study of its effect on maternal and Foetal outcome. J Assoc Physicians India. 2015;63(1):28\u201333.","journal-title":"J Assoc Physicians India"},{"issue":"8","key":"3116_CR66","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/hepr.12028","volume":"43","author":"GD Salam","year":"2013","unstructured":"Salam GD, Kumar A, Kar P, Aggarwal S, Husain A, Sharma S. Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. Hepatol Res. 2013;43(8):826\u201335.","journal-title":"Hepatol Res"},{"issue":"1","key":"3116_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF02722743","volume":"70","author":"S Singh","year":"2003","unstructured":"Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr. 2003;70(1):37\u20139.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"3116_CR68","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12664-016-0704-6","volume":"35","author":"D Solanke","year":"2016","unstructured":"Solanke D, Rathi C, Pandey V, Patil M, Phadke A, Sawant P. Etiology, clinical profile, and outcome of liver disease in pregnancy with predictors of maternal mortality: a prospective study from Western India. Indian J Gastroenterol. 2016;35(6):450\u20138.","journal-title":"Indian J Gastroenterol"},{"issue":"6\u20137","key":"3116_CR69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/00365540310010930","volume":"35","author":"RT Strand","year":"2003","unstructured":"Strand RT, Franque-Ranque M, Bergstr\u00f6m S, Weiland O. Infectious aetiology of jaundice among pregnant women in Angola. Scand J Infect Dis. 2003;35(6\u20137):401\u20133.","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"3116_CR70","first-page":"127","volume":"24","author":"R Sultana","year":"2014","unstructured":"Sultana R, Humayun S. Fetomaternal outcome in acute hepatitis E. J Coll Phys Surg Pak. 2014;24(2):127\u201330.","journal-title":"J Coll Phys Surg Pak"},{"issue":"4","key":"3116_CR71","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jmv.20314","volume":"75","author":"IGP Surya","year":"2005","unstructured":"Surya IGP, Kornia K, Suwardewa TGA, Mulyanto, Tsuda F, Mishiro S. Serological markers of hepatitis B, C, and E viruses and human immunodeficiency virus type-1 infections in pregnant women in Bali, Indonesia. J Med Virol. 2005;75(4):499\u2013503.","journal-title":"J Med Virol"},{"issue":"11","key":"3116_CR72","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/jmv.25545","volume":"91","author":"AF Modiyinji","year":"2019","unstructured":"Modiyinji AF, Amougou-Atsama M, Monamele CG, Nola M, Njouom R. Seroprevalence of hepatitis E virus antibodies in different human populations of Cameroon. J Med Virol. 2019;91(11):1989\u201394.","journal-title":"J Med Virol"},{"issue":"1","key":"3116_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4269\/ajtmh.19-0020","volume":"101","author":"A Tejada-Strop","year":"2019","unstructured":"Tejada-Strop A, Tohme RA, Andre-Alboth J, Childs L, Ji X, Landgraf DO, De Castro V, Boncy J, Kamili S. Seroprevalence of hepatitis a and hepatitis e viruses among pregnant women in Haiti. Am J Trop Med Hyg. 2019;101(1):230\u20132.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"3116_CR74","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/hep.25505","volume":"55","author":"DB Rein","year":"2005","unstructured":"Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in. Hepatology (Baltimore, Md) 2012. 2005;55(4):988\u201397.","journal-title":"Hepatology (Baltimore, Md) 2012"},{"issue":"3","key":"3116_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/2229-5151.119196","volume":"3","author":"I Lata","year":"2013","unstructured":"Lata I. Hepatobiliary diseases during pregnancy and their management: an update. Int J Crit Illness Inj Sci. 2013;3(3):175\u201382.","journal-title":"Int J Crit Illness Inj Sci"},{"issue":"17","key":"3116_CR76","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1517\/14656560903304071","volume":"10","author":"S Fiore","year":"2009","unstructured":"Fiore S, Savasi V. Treatment of viral hepatitis in pregnancy. Expert Opin Pharmacother. 2009;10(17):2801\u20139.","journal-title":"Expert Opin Pharmacother"},{"key":"3116_CR77","unstructured":"WHO: Hepatitis E vaccine: WHO position paper, May 2015. http:\/\/www.who.int\/wer\/2015\/wer9018.pdf?ua=1. Accessed 14 July 2018."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-03116-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03116-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:25:35Z","timestamp":1650536735000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03116-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03116-2","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"13 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}